Cascades Capital Asset Management, LLC Abbott Laboratories Transaction History
Cascades Capital Asset Management, LLC
- $185 Billion
- Q1 2025
A detailed history of Cascades Capital Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cascades Capital Asset Management, LLC holds 1,680 shares of ABT stock, worth $225,590. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,680Holding current value
$225,590% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.38BCall Options Held
9.71MPut Options Held
8.86M-
Vanguard Group Inc Valley Forge, PA170MShares$22.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.97 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.81 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...